These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26847706)

  • 21. MiR-200c promotes papillary thyroid cancer cell proliferation, migration, and invasion by downregulating PTEN.
    Guo K; Wang J; Shu L; Zhou G
    Tissue Cell; 2021 Dec; 73():101647. PubMed ID: 34543800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
    Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C
    J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling.
    Zhang X; Li M; Zuo K; Li D; Ye M; Ding L; Cai H; Fu D; Fan Y; Lv Z
    J Clin Endocrinol Metab; 2013 Aug; 98(8):E1305-13. PubMed ID: 23796566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-381-3p inhibits proliferation, migration and invasion by targeting LRP6 in papillary thyroid carcinoma.
    Kong W; Yang L; Li PP; Kong QQ; Wang HY; Han GX; Wang QB
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3804-3811. PubMed ID: 29949156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-141-3p Suppresses Tumor Growth and Metastasis in Papillary Thyroid Cancer via Targeting Yin Yang 1.
    Fang M; Huang W; Wu X; Gao Y; Ou J; Zhang X; Li Y
    Anat Rec (Hoboken); 2019 Feb; 302(2):258-268. PubMed ID: 30290400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
    Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J
    Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of MiR-431 expression associated with lymph node metastasis and promotes cell invasion in papillary thyroid carcinoma.
    Liu Y; Li L; Liu Z; Yuan Q; Lu X
    Cancer Biomark; 2018; 22(4):727-732. PubMed ID: 29945344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.
    Czajka AA; Wójcicka A; Kubiak A; Kotlarek M; Bakuła-Zalewska E; Koperski Ł; Wiechno W; Jażdżewski K
    PLoS One; 2016; 11(3):e0151968. PubMed ID: 27011326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-145 functions as a tumor suppressor in Papillary Thyroid Cancer by inhibiting RAB5C.
    Zhang W; Ji W; Li T; Liu T; Zhao X
    Int J Med Sci; 2020; 17(13):1992-2001. PubMed ID: 32788878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-630 inhibits papillary thyroid carcinoma cell growth, metastasis, and epithelial-mesenchymal transition by suppressing JAK2/STAT3 signaling pathway.
    Pan XM; He XY; Yang YL; Jia WJ; Yang ZQ; Yan D; Ma JX
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2453-2460. PubMed ID: 30964171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2.
    Qiu W; Yang Z; Fan Y; Zheng Q
    Oncotarget; 2016 Jun; 7(26):39907-39915. PubMed ID: 27223438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
    Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
    Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
    [No Abstract]   [Full Text] [Related]  

  • 39. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
    Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
    J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-150 targets Rho-associated protein kinase 1 to inhibit cell proliferation, migration and invasion in papillary thyroid carcinoma.
    Cheng L; Zhou R; Chen M; Feng L; Li H
    Mol Med Rep; 2017 Aug; 16(2):2217-2224. PubMed ID: 28656254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.